In patients receiving brachytherapy for the treatment of genitourinary cancers, is women’s sexual health being assessed in the clinic at the same rate as their male counterparts? Takayesu et al examined this question in a report presented at the 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting (Abstract 2306).
